|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 701 Pennsylvania Ave., NW Suite 720 |
Address2 | |
| City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 5632-12
|
||||||||
|
6. House ID# 312570000
|
||||||||
| TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Ronald F. Docksai, Ph.D. Vice President Federal Government Relations |
Date | 10/20/2008 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
S. 3289 An original bill making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2009, and for other purposes; (Provisions relating to continued funding for the National Agricultural Statistics Service.)
S. 3385 A bill to provide for enhanced food-borne illness surveillance and food safety capacity; (Provisions relating to food safety.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
H.Res. 829 Recognizing the KC Animal Health Corridor from....Kansas to Missouri; (Support for this resolution.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
H.R. 1232/S. 746 to establish a competitive grant program to build capacity in veterinary medical education and expand the workforce of veterinarians engaged in public health practice and biomedical research; (Section 2. Competitive Grants Program.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
H.R. 21 To establish a national policy for our oceans, to strengthen the National Oceanic and Atmospheric Administration, to establish a national and regional ocean governance structure, and for other purposes; (Provisions relating to a national oceans policy and its impact on farming.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
S. 2191 America's Climate Security Act of 2007; (All provisions relating to implementation of a comprehensive greenhouse gas registry and control cap and trade program.)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CHM
16. Specific lobbying issues
H.R. 5577 To amend the Homeland Security Act of 2002 to extend, modify, and recodify the authority of the Secretary of Homeland Security to enhance security and protect against acts of terrorism against chemical facilities, and for other purposes; (Provisions relating to Inherently Safer Technology and State Preemption.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
H.R. 5629 Pathway for Biosimilars Act; (Sections concerning data exclusivity.)
S. 1145 To amend Title 35, USC, The Patent Reform Act; (Section to provide patent reform.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
H.R. 1887/S. 1179 Superfund Equity and Megasite Remediation Act of 2007; (All provisions pertaining to amendments of the Internal Revenue code of 1986 to extend the financing for superfund for purposes of clean-up activities with respect to those Superfund sites for which removal and remedial action is estimated to cost more than $50,000,000, and for other purposes.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
H.R. 1148 Safe Food Act 2007; (Title II, Monitoring provisions relating to administration of Food Safety Programs.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
USA Canada Tax Treaty -- Protocol Number 110-15; (All provisions relating to taxes, corporate compliance and arbitration.)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald F. |
Docksai |
Dr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1038/S. 623 Biologics Price Competition and Innovation Act; (Biologic licensing provisions.)
H.R. 3700/S. 1951 Fair Medicaid Drug Payments Act of 2007; (Amendments to Title XIX provisions regarding the Social Security Act.)
H.R. 4 Medicare Prescription Drug Price Negotiation Act of 2007; (Amending part D of Title XViii of the Social Secuity Act.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald F. |
Docksai |
Dr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 2928 BPA Kids Free Act; (All provisions relating to banning bisphenol A in children's products.)
H.R. 4040 Consumer Product Safety Commission Modernization Act of 2008 (All provisions relating to the establishment of consumer product safety standards and other safety requirements for children's products and to reauthorize and modernize the Consumer Product Safety Commission.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 2029 Physician Payments Sunshine Act of 2007; (Provisions relating to entire bill.)
S. 2221 Transparency in Medical Device Pricing Act of 2007; (Provisions relating to entire bill.)
H.R. 5629 Pathways for Biosimilars Act; (Sections concerning data exclusivity.)
S. 2499 The Medicare, Medicaid, and SCHIP Extension Act of 2007; (Section 113)
H.R. 970/S. 1378 To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug Dextromethorphan, and for other purposes; (Sections pertaining to DXM.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 962/S. 549 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. Relating to definition of the use of critical antimicrobial animal drugs in agriculture.)
H.R. 3697/S. 2313 Strategies to Address Antimicrobial Resistance; (Section 3(c) relating to authorities over antimicrobial drug
approval.)
HR 6432 To amend the Federal food, Drug, and Cosmetic Act to revise and extend the animal drug user fee program, and for other purposes; (All sections.)
HR 3610 Food and Drug Import Safety Act of 2007; (Provisions relating to user fees.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
H.R. 5577 Chemical Facility Security Plans; (All provisions relating to rules that allow the government to approve a site security plan for a chemical facility.)
H.R. 5533 Chemical Plant Facility Plans; (All provisions relating to rules that allow the government to approve a site security plan for a chemical facility.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
H.R. 1908/ S. 1145 Patent Reform Act of 2007; (All provisions amending Title 35 of US Code regarding patents.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald F. |
Docksai |
Dr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
S. 3335 The Jobs, Energy , Families and Disaster Relief Act of 2008; (Included provisions concerning R & D Tax credit.)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 2499 The Medicare, Medicaid, and SCHIP Extension Act of 2007; (Section 113)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
H.R. 4083/S. 2311 Non-Prescription Drug Modernization Act of 2007; (Amending the FDCA, re: monographs and advertising.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ronald F. |
Docksai |
Dr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
H.R. 970/S. 1378 To amend the Federal Food, Drug and Cosmetic Act with respect to the distribution of the drug Dextromethorphan, and for other purposes; (Sections pertaining to DXM.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code RRR
16. Specific lobbying issues
H.R. 1650/S. 772 The Railroad Anti-Trust Enforcement Act; (All provisions relating to amendments that will provide expanded coverage to the Federal Anti-Trust laws to eliminate exemptions from such laws that are contrary to the public interest with respect to railroalds.)
H.R. 2125/S. 953 The Rail Competition and Service Improvement Act of 2007; (All provisions relating to amendments that will
ensure the competition in the rail industry, enable rail customers to obtain reliable rail servie, and provide those customers with a reasonable process for challenging rate and service disputes.)
S. 1125 The Freight Rail Capacity Expansion Act of 2007; (All provisions pertaining to incentives to encourage investment in the expansion of freight rail infrastructure capacity through changes to the Internal Revenue Code of 1986 and to enhance modal tax equity.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
S. 3335 The Jobs, Energy, Families and Disaster Relief Act of 2008; (Included provisions concerning R&D Tax credit.)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas B. |
Lilburn |
Mr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
H.R. 1830 The Andean Trade Preferences Extension Package; (All provisions pertaining to the extension for eight months through February of 2008, duty free treatment of certain products from Bolivia, Columbia, Ecuador and Peru.)
H.R. 5301 To temporarily suspend the duty of Acetyl Salicylic acid; (Provisions relating to the reduction of tariffs.)
H.R. 5304 To temporarily suspend the duty of Sorafenib-Bay54; (Provisions relating to the reduction of tarfiffs.)
H.R. 5072 To temporarily suspend the duty of Arcol Catalyst 3; (Provisions related to the reduction of tariffs.)
H.R. 5302 To temporarily suspend the duty of D-Mannose; (Provisions related to the reduction of tariffs.)
H.R. 5303 To temporarily suspend the duty of Sedran Technical; (Provisions related to the reduction of tariffs.)
H.R. 5073 To temporarily suspend the duty of Crelan VP LS 2147; (Provisions related to the reduction of tariffs.)
H.R. 5074 To temporarily suspend the duty of Desmodur RF-E; (Provisions related to the reduction of tariffs.)
H.R. 5078 To temporarily suspend the duty of Desmodur BL XP 2468; (Provisions related to the reduction of tariffs.)
H.R. 5080 To temporarily suspend the duty of Desmodur HL BA; (Provisions related to the reduction of tariffs.)
H.R. 5083 To temporarily suspend the duty of Desmodur E 14; (Provisions related to the reduction of tariffs.)
H.R. 5075 To temporarily suspend the duty of Desmodur RE; (Provisions related to the reduction of tariffs.)
H.R. 5081 To temporarily suspend the duty of VP LS 2253; (Provisions related to the reduction of tariffs.)
H.R. 5077 To temporarily suspend the duty of TSME; (Provisions related to the reduction of tariffs.)
H.R. 5079 To temporarily suspend the duty of Xama 2; (Provisions related to the reduction of tariffs.)
H.R. 5070 To temporarily suspend the duty of Xama 7; (Provisions related to the reduction of tariffs.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
H.R.4653 To extend the temporary suspension of duty on ACM; (Provisions relating to the reduction of tariffs.)
H.R.4654 To extend the temporary suspension of duty on Oxadiazon; (Provisions relating to the reduction of tariffs.)
H.R.4635 To suspend temporarily the duty on Product mixtures containing Thiencarbazone-methyl (Methyl 4-({Y(3-methoxy-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-tria zol-1-yl)carbonyl?amino} sulfonyl)-5-methylthiophene-3-caroxylate) & Isoxadifen-ethyl (ethyl 4,5-dihydro-5,5-diphenyl-1,2-oxazole-3-carboxylate) & Isoxaflutole(5-Cyclospropyl-4-(2-Methylsulfonyl-4-Trifluorom ethylbenxoyl)Isoxazole)); (Provisions relating to the reduction of tariffs.)
H.R.4636 To suspend temporarily the duy on Cyprosulfamide: N-( {4-YCyclopropylamino) carbonyl?phenyl}sulfonyl)-2-methoxybenzamide (CAS No. Cyprosulfamide: 221667-31-8); (Provisions relating to the reduction of tariffs.)
H.R.4630 To suspend temporarily the duty on 2-Chloro-6-(methylthio)toluene; (Provisions relating to the reduction of tariffs.)
H.R.4629 To suspend temporarily the duty on 2-(Methylthio)-4-(trifluoromethyl) benzoic acid; (Provisions relating to the reduction of tariffs.)
H.R.4633 To suspend temporarily the duty on 1,3-Dimethyl-1H-pyrazol-5-ol and 1,3-Dimethylpyrazol-5-one; (Provisions relating to the reduction of tariffs.)
H.R.4631 To suspend temporarily the duty on products containing 3-Mesityl-2-oxo-1-oxaspiroY4.4?non-3-en-4-yl 3,3-dimethylbutyrate; (Provisions relating to the reduction of tariffs.)
H.R.4632 To suspend temporarily the duty on mixtures containing Pyrasulfotole: 5-Hydroxy-1,3-dimethylpyrazol-4-yl 2-mesyl-4-(trifluoromethyl)phenyl ketone; and Bromoxynil Octanoate: 2,4-Dibromo-6-cyanophenyl octanoate; and Bromoxynil Heptanoate: 2,4-Dibromo-6-cyanophenyl heptanoate; (Provisions relating to the reduction of tariffs.)
H.R.4634 To suspend temporarily the duty on Products containing ( ) -2-ethoxy-2,3-dihydro-3,3-diemthylbenzofuran-5-yl methansulfonate; (Provisions relating to the reduction of tariffs.)
H.R.4628 To suspend temporarily the duty on products containing (E)-N-Y(2-Chloro-1,3-thiazol-5-yl) methyl?-N-methylYoxido(oxo)hydrazono? methanediamine or N-Y(2-Chloro-1,3-thiazol-5-yl)methyl?-N-{(E)-(methylamino) Yoxido(oxo)hydrazono? methyl}-amine; (Provisions relating to the reduction of tariffs.)
H.R.4591 To suspend temporarily the duty on 1,3-Cyclohexanedione; (Provisions relating to the reduction of tariffs.)
H.R.4599 To extend the temporary suspension of duty on 2-Acetylbutyrolactone; (Provisions relating to the reduction of tariffs.)
H.R.4590 To suspend temporarily the duty on AE 0172747 Ether; (Provisions relating to the reduction of tariffs.)
H.R.4595 To suspend temporarily the duty on Mixtures containing 4-(2-Methylsulfonyl-4-trifluoromethyl-benzoyl)-5-cyclopropyl soxazole; (Provisiosn relating to the reduction of tariffs.)
H.R.4600 To extend the temporary suspension of duty on -Cyfluthrin; (Provisions relating to the reduction of tariffs.)
H.R.4602 To extend the temporary suspension of duty on Clothianidin; (Provisions relating to the reduction of tariffs.)
H.R.4601 To extend the temporary suspension of duty on Cyfluthrin; (Provisions relating to the reduction of tariffs.)
H.R.4604 To extend the temporary suspension of duty on product mixtures containing Foramsulfuron and Iodosulfuronmethyl-sodium; (Provisions relating to the reduction of tariffs.)
H.R.4603 To extend the temporary suspension of duty on Ethoprop; (Provisions relating to the reduction of tariffs.)
H.R.4589 To suspend temporarily the duty on Flubendiamide; (Provisions relating to the reduction of tariffs.)
H.R.4609 To extend the temporary suspension of duty on FOE Hydroxy; (Provisions relating to the reduction of tariffs.)
H.R.4605 To extend the temporary suspension of duty on Isoxadifen-Ethyl; (Provisions relating to the reduction of tariffs.)
H.R.4597 To suspend temporarily the duty on Isoxaflutole; (Provisions relating to the reduction of tariffs.)
H.R.4587 To suspend temporarily the duty on Olympus WG70; (Provisions relating to the reduction of tariffs.)
H.R.4594 To extend the temporary suspension of duty on 4-Chlorobenzaldehyde; (Provisions relating to the reduction of tariffs.)
H.R.4598 To extend the temporary suspension of duty on Iprodione; (Provisiosn relating to the reduction of tariffs.)
H.R.4607 To extend the temporary suspension of duty on Spiromesifen; (Provisions relating to the reduction of tariffs.)
H.R.4588 To suspend temporarily the duty on Spirotetramat; (Provisions relating to the reduction of tariffs.)
H.R.4610 To suspend temporarily the duty on Tembotrione; (Provisions relating to the reduction of tariffs.)
H.R.4608 To suspend temporarily the duty on Thiencarbazone-methyl; (Provisions relating to the reduction of tariffs.)
H.R.4606 To extend the temporary suspension of duty on Trifloxystrobin; (Provisions relating to the reduction of tariffs.)
H.R.5117 To extend the temporary suspension of duty on 2,4-Dichloroaniline; (Provisions relating to the reduction of tariffs.)
H.R.5398 To suspend temporarily the duty on certain mixtures containing Y3-Y(6--chloro-3-pridinyl)methyl?-2-thiazolidinylidene?cyana ide; (Provisions relating to the reduction of tariffs.)
H.R.5121 To extend the temporary reduction of duty on cyclopropane-1,1-dicarboxylic acid, dimethyl ester; (Provisions relating to the reduction of tariffs.)
H.R.5118 To extend the temporary suspension of duty on Aluminum tris (O-ethylphosphonate); (Provisions relating to the reduction of tariffs.)
H.R.5122 To suspend temporarily the duty on Pyrasulfotole; (Provisions relating to the reduction of tariffs.)
H.R.5123 To extend the temporary suspension of duty on Pyrimethanil; (Provisions relating to the reduction of tariffs.)
H.R.5278 To extend the temporary suspension of duty on Option and Revolver herbicides; (Provisions relating to the reduction of tariffs.)
H.R.5274 To reduce temporarily the duty on Imidacloprid Pesticides; (Provisions relating to the reduction of tariffs.)
H.R.5277 To extend the temporary suspension of duty on Imidacloprid Technical; (Provisions relating to the reduction of tariffs.)
H.R.5039 To suspend temporarily the duty on 1,2,4 Triazole; (Provisions relating to the reduction of tariffs.)
H.R.5042 To suspend temporarily the duty on Belt & Synapse; (Provisions relating to the reduction of tariffs.)
H.R.5041 To suspend temporarily the duty on Fenhexamid; (Provisions relating to the reduction of tariffs.)
H.R.5040 To suspend temporarily the duty on Fluopicolide; (Provisions relating to the reduction of tariffs.)
H.R.5045 To extend the temporary suspension of duty on Previcur; (Provisions relating to the reduction of tariffs.)
H.R.5044 To extend the temporary suspension of duty on Propiconazole; (Provisions relating to the reduction of tariffs.)
H.R.5419 To suspend temporarily the duty on product mixtures containing Imidacloprid: 1-(6-Chloro-3-pyridinyl)methyl-N-nitroimidazolidin-2-ylidene amine Z9: (9Z)-9-Tricosene; (Provisions relating to the reduction of tariffs.)
H.R.5418 To extend the temporary suspension of duty on 2-Chloro benzyl chloride; (Provisions relating to the reduction of tariffs.)
H.R.5417 To extend the temporary suspension of duty on Permethrin; (Provisions relating to the reduction of tariffs.)
H.R.5414 To suspend temporarily the duty on Phosphorus Thiochloride; (Provisions relating to the reduction of tariffs.)
H.R.5120 To extend the temporary suspension of duty on Fenamidone; (Provisions relating to the reduction of tariffs.)
H.R.5119 To suspend temporarily the duty on 2,2-Dimethylbutanoic acid 3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro(4.5)dec-3-en-4-yl ester; (Provisions relating to the the reduction of tariffs.)
H.R.5333 To extend the temporary suspension of duty on 2,6-dibromo-4-cyanophenyl octanoate/heptanoate; (Provisions relating to the reduction of tariffs.)
H.R.5332 To extend the temporary suspension of duty on Desmedipham in bulk or mixtures; (Provisions relating to the reduction of tariffs.)
H.R.5043 To extend the temporary suspension of duty on Phenmedipham; (Provisions relating to the reduction of tariffs.)
H.R.4998 To extend the temporary suspension of duty on mixtures of methyl 4-iodo-2-Y3-(4-methoxy-6-methyl-1,3,5- triazin-2-yl)ureidosulfonyl? benzoate, sodium salt(Iodosulfuron methyl, sodium salt) and application adjuvants; (Provisions relating to the reduction of tariffs.)
H.R.4999 To extend the temporary suspension of duty on Mesosulfuronmethyl; (Provisions relating to the reduction of tariffs.)
H.R.5000 To suspend temporarily the duty on mixtures containing (R)-2-Y4-(6-chloro-1,3-benzoxazol-2-yloxy)phenoxy?propionate (Fenoxaprop Ethyl), (CAS No. 71283-80-2), 5-hydroxy-1,3-dmiethylpyrazol-4-yl 2-mesyl-4-(trifluoromethyl)phenyl ketone (Pyrafulfotole) (CAS No. 365400-11-9), 2,6-dibromo-4-cyanophenyl octanoate (Bromoxynil octanoate) (CAS No. 1689-99-2), and 2,6-dibromo-4-cyanophenyl heptanoate (Bromoxynil heptanoate) (CAS No. 56634-95-8); (Provisions relating to the reduction of tariffs.)
H.R.5421 To extend the temporary suspension of duty on N-3Y3-(1-methylethoxy)phenyl?-2-(trifluoromethyl)benzamide; (Provisions relating to the reduction of tariffs.)
H.R.5420 To extend the temporary suspension of duty on Resmethrin; (Provisions relating to the reduction of tariffs.)
H.R.5422 To extend the temporary suspension of duty on mixtures containing methyl 2-(4,5-dihydro-4-methyl-5-oxo-3-propoxy-1H-1,2,4-triazol-1-y l)carboxamidosulfonylbenzoate; sodium (4,5-dihydro-4-methyl-5-oxo-3-propoxy-1H-1,2,4-triazol-1-ylc arbonyl)(2-methoxycarbonylphenylsulfonyl)azanide & methyl 4-iodo-2-Y3-(4-methoxy-6-methy; (Provisions relating to the reduction of tariffs.)
H.R.5415 To suspend temporarily the duty on Sodium Methylate; (Provisions relating to the reduction of tariffs.)
H.R.5416 To suspend temporarily the duty on Spiroxamine; (Provisions relating to the reduction of tariffs.)
H.R.5413 To suspend temporarily the duty on Thionyl chloride; (Provisions relating to the reduction of tariffs.)
H.R.5334 To suspend temporarily the duty on product mixtures containing Methyl 2-Y({Y(4,6-dimethoxy-2-pyrimidinyl)amino?carbonyl}amino)sulf onyl?-4-Y(mesylamino)methyl?benzoate Methyl 4-iodo-2-Y3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosul fonyl?benzoate, sodium salt; (Provisions relating to the reduction of tariffs.)
H.R.4592 To suspend temporarily the duty on certain mixtures containing Thiencarbazone-methyl and Isoxadifen-ethyl and Isoxaflutole; (Provisions relating to the reduction of tariffs.)
H.R.4593 To extend the temporary suspension of duty on Trichloroacetaldehyde; (Provisions relating to the reduction of tariffs.)
H.R.5457 To extend the temporary suspension of duty on Deltamethrin; (Provisions relating to the reduction of tariffs.)
H.R.5458 To suspend temporarily the duty on Hydrazine monohydrate; (Provisions relating to the reduction of tariffs.)
H.R.5456 To suspend temporarily the duty on Tembotrione; (Provisions relating to the reduction of tariffs.)
H.R.5459 To extend the temporary suspension of duty on Triadimefon (Provisions relating to the reduction of tariffs.)
H.R.5272 To reduce temporarily the duty on Corvus herbicide; (Provisions relating to the reduction of tariffs.)
H.R.5273 To reduce temporarily the duty on Evergol; (Provisions relating to the reduction of tariffs.)
H.R.5275 To suspend temporarily the duty on Liberty, Rely, and Ignite herbicides; (Provisions relating to the reduction of tariffs.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean D. |
Reimers |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
HR 6049 Energy and Tax Extenders Act of 2008; (All provisions related to extension of energy tax credits and renewable tax credits related to the supply of natural gas and oil and royalties.)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
Ms. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | 701 Pennsylvania Ave., NW Suite 720 |
||||||
| City | Washington, |
State | DC |
Zip Code | 20004-2626 |
Country | USA |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
5 |
|
||||||
| 2 |
|
6 |
|
||||||
| 3 |
|
7 |
|
||||||
| 4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 3 | 5 |
| 2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 5 | 9 |
| 2 | 6 | 10 |
| 3 | 7 | 11 |
| 4 | 8 | 12 |